Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed at growing the horizons of cytokine-based immunotherapy, especially for cancers where therapy options remain limited. Utilize the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline We https://financefeeds.com/sucden-financial-taps-nadsaq-risk-platform-for-real-time-risk-management/